Skip to content

The feasible of opioid-free anesthesia with Esketamine ,Dexmedetomidine and Sevoflurane for medium and small- sized surgery

The feasible of opioid-free anesthesia with Esketamine ,Dexmedetomidine and Sevoflurane for medium and small- sized surgery

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300069061
Enrollment
Unknown
Registered
2023-03-06
Start date
2023-03-06
Completion date
Unknown
Last updated
2023-05-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

The use of opioid-free anesthesia for medium to small-sized surgery

Interventions

Control group:Opioid drugs anesthesia
S-KTM Group:opioid-free anesthesia,S-ketamine and other narcotic drugs were used for anesthesia

Sponsors

The Affiliated Hospital of Qingdao University,Qingdao,China
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. The age range is between 18 and 65 years old 2.undergo small to medium sized surgery,ASA1-3 grade 3.Patients participate voluntarily

Exclusion criteria

Exclusion criteria: 1.Allergies to study medications 2.ASA>grade3 3.Pregnancy and lactation 4.History of motion sickness 5.History of drug addiction, history of chronic pain, history of chronic opioid use (daily opioid use >3 months 6.Chronic kidney disease (serum creatinine >200µmol dl-1) 7. Subjects with known allergies or adverse reactions to S-ketamine, ketamine, patients with a history of mental illness such as mania or depression, or those with speech disorders.

Design outcomes

Primary

MeasureTime frame
the incidence of postoperative nausea and vomiting (PONV) and?rescue treatment;Postoperative respiratory;pain condition and rescue treatment;

Secondary

MeasureTime frame
Postoperative exhaust time;Inpatient Length of Stay;Adverse reactions;

Countries

China

Contacts

Public ContactWei Feng

The Affiliated Hospital of Qingdao University,Qingdao,China

fengweisdqd@qdu.edu.cn18661805500

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026